节点文献

VEGF和N-Ras及pERK1/2在急性髓系白血病骨髓中的表达及相关性研究

Correlation between the expression of VEGF and N-ras/pERK1/2 signal pathway and its clinical significance in acute myeloid leukemia

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 樊华杜宏张国君王萍萍王艳萍卢香兰李霞金锋

【Author】 FAN Hua, DU Hong, ZHANG Guo-jun, WANG Ping-ping, WANG Yan-ping, LU Xiang-lan, LI Xia, JIN FengFirst Affiliated Hospital, China Medical University, Shenyang 110001, P.R.China

【机构】 中国医科大学附属第一医院血液科中国医科大学附属第一医院肿瘤科 辽宁沈阳110001辽宁沈阳110001

【摘要】 目的:研究VEGF、NRas和pERK1/2在急性髓系白血病(AML)中的表达及临床意义,探讨白血病发展过程中VEGF的表达与Ras/MAPK信号通路之间的相互关系。方法:应用免疫组织化学染色法检测骨髓单个核细胞VEGF、NRas和pERK1/2蛋白的水平,应用PCR/RFLP、PCRSSCP和DNA测序方法对初诊和完全缓解(CR)AML患者进行Nras基因12位点突变分析。结果:检测AML46例,在初诊组28例AML中,VEGF、Nras和pERK1/2的表达[(52.1±0.31)%、(59.8±0.32)%和(41.9±0.38)%]显著高于20例对照组[(20.5±0.16)%、(20.9±0.12)%和(14.1±0.14)%],P=0.034、P=0.008和P=0.005。CR组18例AML患者中,VEGF、NRas和pERK1/2的表达[(18.6±0.18)%、(28.2±0.27)%和(15.1±0.19)%]与对照组差异无统计学意义,P>0.05、P=0.411和P=0.343。初诊组VEGF、Nras和pERK1/2的表达较CR组显著增高,P=0.029、P=0.018和P=0.008。初诊和CR组中未发现Nras基因12位点突变。VEGF与Nras和pERK1/2表达水平相关性分析结果表明,VEGF的表达与NRas和pERK1/2的表达具有密切相关性(VEGF与NRas:r=0.510,P=0.003;VEGF与pERK1/2:r=0.513,P=0.003;VEGF与pERK1/2:r=0.464,P=0.009)。结论:VEGF和NRas/ERK信号传导通路共同参与了AML的发展过程,NRas/ERK信号传导通路的工作状态与Nras基因突变关系不密切。

【Abstract】 OBJECTIVE: To investigate the expression of VEGF, N-Ras and pERK1/2,in order to clarify the relationship between the expression of VEGF and N-Ras/ERK signal pathway in the development of human acute myeloid leukemia(AML). METHODS: The expression level of VEGF, N-Ras and pERK1/2 was checked in the samples of bone marrow mononuclear cells from 46 diagnosed AML patients using immunohistochemistry method, and mutation analysis at N-ras codon 12 was finished using the method of PCR/RFLP, PCR/SSCP and DNA sequencing analysis. RESULTS: The expression of VEGF, N-Ras and pERK1/2 were significantly higher in 28 cases of newly diagnosed AML patients [(52.1±0.31)%,(59.8±0.32)%,(41.9±0.38)%,respectively] than that of 20 cases of normal control [(20.5±0.16)%,(20.9±0.12)%,(14.1±0.14)%;P=0.034,P=0.008,P=0.005, respectively],and that of 18 cases of complete remission AML(CR AML)[(18.6±0.18)%,(28.2±0.27)%,(15.1±0.19)%;P=0.029, P=0.018 ,P=0.008,respectively]; meanwhile, there was no significant different for the expression level of VEGF, N-Ras and pERK1/2 between the group of CR AML and normal control (P>0.05, P=0.411, P=0.343). There was no mutation at N-ras codon 12 in all of patients suffering from AML. Close relationship was founded between the expression of VEGF, N-Ras and pERK1/2 (VEGF & N-Ras:r=0.510,P=0.003;VEGF & pERK1/2:r=0.513,P=0.003;VEGF & pERK1/2:r=0.464,P=0.009). CONCLUSIONS: VEGF, cooperating with N-Ras/ERK signal pathway play some roles, and N-Ras/ERK signal pathway was seldom affected, if not all, by N-ras mutation, in the development of human acute myeloid leukemia.

【关键词】 白血病VEGFNRasERK
【Key words】 leukemiaVEGFN-RasERK
【基金】 辽宁省自然科学基金资助(20042098)
  • 【文献出处】 肿瘤防治杂志 ,Journal of Qilu Oncology , 编辑部邮箱 ,2005年12期
  • 【分类号】R733.71
  • 【被引频次】9
  • 【下载频次】226
节点文献中: 

本文链接的文献网络图示:

本文的引文网络